Comprehensive Support for the NHLBI BioLINCC Program

As a trusted partner to the National Heart, Lung, and Blood Institute (NHLBI), IMS developed and maintains the Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC), a secure, centralized data sharing platform.

Impact & Growth

A measurable impact on reuse & research.

BioLINCC advances NHLBI research by giving qualified investigators access to high value clinical and observational study data and biospecimen collections that support studies in the heart, lungs, blood, and related diseases.

Research Platforms

2,200 publications
written with BioLINCC data

300 packages
of curated data available

60 collections
of biospecimens available for request

2.6M+ specimens
accessible to researchers

Studying. Improving. Deploying.

Since 2009, our team has delivered end to end expertise, from data ingestion and curation to dissemination, while continually enhancing the BioLINCC system to simplify data discovery, strengthen compliance, and support efficient, user friendly request workflows.

We regularly collaborate with NHLBI to study the impact and usefulness of the BioLINCC software and incorporate feedback from researchers and the NHLBI in routine updates.

Demand continues to rise, with 1,388 datasets distributed between October 2024 and September 2025 alone.

What We Built

All the features needed for biospecimen and data requests.

Researchers use BioLINCC to grant obtain to data and biorepository resources and report resulting publications which are searchable on the BioLINCC website.

Specialized Software

Continually enhanced with security improvements, and new features that respond to evolving research and policy needs

Search & Discovery

Powerful search and filtering tools to quickly find studies and narrow results by collection type, biospecimen material, keywords, study dates, and other key attributes

Tracking & Fulfillment

Custom workflows allow researchers to submit requests and track progress while IMS oversees the review process and the secure delivery of approved data and biospecimens

Approval & Voting

Dedicated workspace that supports comments and approval voting to evaluate submitted protocols, analysis plans, and requests

Regulatory Compliance

Privacy-first & industry-specific platform design.

Data Sharing Policies

BioLINCC collects and enforces standardized agreement templates, including the Research Materials Distribution Agreement (RMDA) and Incoming Biospecimen Material Transfer Agreement (MTA), and automatically generates required agreements based on the study and resources involved. Each collection comes with clearly presented informed consent documentation and restrictions.

Identity Verification

We use NIST IAL2 identity verification and detailed requestor information to confirm eligibility for users accessing the platform.

Controlled Access Data Repository (CADR)

BioLINCC conforms to NIH controlled-access data repository standards, ensuring secure, policy-compliant sharing of sensitive data and biospecimens with qualified researchers.

CADR Research Platforms

Data Processing

Maintaining the data pipeline from acquisition to dissemination.

  • Acquisition
    IMS coordinates directly with submitting studies and pre-reviews required documentation and study details before formal NHLBI evaluation, reducing review cycles and improving submission quality.
  • Documentation
    For each BioLINCC study, we provide clear documentation, including a BioLINCC-generated Data Dictionary and relevant study materials to help researchers understand and use the data.
  • Linkage
    Our team links IDs in the study-provided data to the biorepository inventory to ensure that all biospecimens received are linked to the clinical data needed for secondary analysis.
  • Curation
    We review all submitted data and redact sensitive information before making data available for request, and include a clear data roadmap to help researchers understand how datasets can be combined for analysis, reducing barriers to reuse and accelerating discovery.
  • Validation & Quality Assurance
    We perform rigorous quality assurance and quality control checks on all data shared through BioLINCC and work closely with NHLBI to support data review tied to biospecimen quality and inventory management.
  • De-Identification & Anonymization
    IMS de-identifies data and biospecimens in accordance with NHLBI data‑submission guidelines. Where required, data or samples are anonymized to prevent subject re-identification and ensure participant privacy.

We use our specialized expertise to ingest, validate, transform, and deliver data for the data coordinating centers that we operate for the NIH and Centers for Disease Control and Prevention projects including BioLINCC.

Collaboration

Close collaboration for curated results.

Presentations, Conferences and Outreach

We work closely with NHLBI to promote BioLINCC through presentations and posters delivered to the research and biobanking communities. Our team regularly participates in ISBER World Biobanking Conferences by staffing booths, speaking in sessions, and presenting posters to raise awareness and encourage adoption of BioLINCC.

IMS has also presented at Leaders for BioBanking conferences and participated in the Society for Clinical Trials Annual Meeting, extending BioLINCC's visibility across clinical research, data sharing, and biorepository audiences.

Metrics and Reporting

IMS develops comprehensive utilization metrics that track repository growth, system usage, and scientific output to help NHLBI assess program performance, inform management decisions, and ensure resources are aligned with research demand.

BioLINCC Publications & presentations

Publications Authored by IMS

IMS and NHLBI have co-authored multiple peer-reviewed studies demonstrating BioLINCC's success in increasing visibility, improving access efficiency, supporting rapid data distribution, and reducing biorepository costs through standardized workflows and technology-driven analysis.

Staff Publications

The NHLBI BioLINCC Operational Guidelines: Streamlining the Review of Biospecimen Requests

Biopreservation and Biobanking. 2011 May; doi: bio.2011.9120. Epub 2011 Apr 7.

Wagner E, Shea K, Carroll L, Welniak L, Berman S, Adams J, Giffen C.

Providing Contemporary Access to Historical Biospecimen Collections: Development of the NHLBI Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC)

Biopreserv Biobank. 2015 Aug;13(4):271-9. doi: 10.1089/bio.2014.0050. Epub 2015 Jul 17. PMID: 26186276; PMCID: PMC4559201.

Giffen CA, Carroll LE, Adams JT, Brennan SP, Coady SA, Wagner EL.

Efficiently Maintaining a National Resource of Historical and Contemporary Biological Collections: The NHLBI Biorepository Model.

Biopreserv Biobank. 2017 Feb;15(1):17-19. doi: 10.1089/bio.2016.0112. PMID: 28186851; PMCID: PMC5326980.

Shea KE, Wagner EL, Marchesani L, Meagher K, Giffen C.

Use of the National Heart, Lung, and Blood Institute Data Repository

N Engl J Med. 2017 May 11;376(19):1849-1858. doi: 10.1056/NEJMsa1603542. Epub 2017 Mar 29. PMID: 28402243; PMCID: PMC5665376.

Coady SA, Mensah GA, Wagner EL, Goldfarb ME, Hitchcock DM, Giffen CA.

Value-added use of clinical study data: a BioLINCC perspective on creating well-annotated data packages for the wider scientific community.

TRIALS. 2017 May; 18:236.

Carroll L, Adams J, Del Vecchio C, Mittu K, Zhou K, Wang J, Giffen C, Wagner E, Coady S.

BioShare
Biospecimen & Dataset Sharing Platform

Interested in your own secure, centralized research data and biospecimen sharing platform? Consider Bioshare, a fully commercialized platform informed by our experience developing and supporting BioLINCC.